Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

NCT00111345 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

550

Enrollment

OTHER

Sponsor class

Conditions

Myeloid Leukemia

Interventions

DRUG: Anthracyclines
DRUG: liposomal daunorubicin
DRUG: 2-CDA
DRUG: AI

Sponsor

University Hospital Muenster

Collaborators

[object Object]